PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Health Decisions

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Health Decisions CEO to Discuss at MAGI Conference - Dr. Michael Rosenberg, CEO of full-service contract research organization Health Decisions, will outline the advantages and requirements of innovative e-monitoring methods, October 25 in San Francisco
Health Decisions CEO to Discuss at MAGI Conference

 

NewswireToday - /newswire/ - Durham, NC, United States, 2010/10/20 - Dr. Michael Rosenberg, CEO of full-service contract research organization Health Decisions, will outline the advantages and requirements of innovative e-monitoring methods, October 25 in San Francisco.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. Michael Rosenberg, CEO of full-service contract research organization Health Decisions, will present a featured session titled “Adaptive Site Monitoring” October 25 at MAGI’s Clinical Research Conference West in San Francisco, CA. Dr. Rosenberg will outline how advanced e-monitoring techniques facilitate a metrics-based approach that reduces field monitoring costs by as much as 50 percent without compromising quality.

According to Dr. Rosenberg, an adaptive monitoring system builds on the same basic principles as adaptive design. But instead of adapting study designs based on interim reviews of patient data, adaptive monitoring optimizes operations based on iterative, day-to-day reviews of operational metrics.

“With the ability to access constant flows of meaningful metrics remotely and in near-real time, monitors can respond more quickly to emerging problems while more efficiently scheduling expensive monitoring visits,” said Dr. Rosenberg. “As a result, drug and device developers experience drastically reduced field monitoring costs, better data quality, more efficient use of resources, and substantially shorter program cycles.”

Part of the conference’s Sponsor Operations track, “Adaptive Site Monitoring (D381)” takes place Monday, October 25 from 3:45 to 4:30 p.m. PDT at The Fairmont San Francisco.

About Health Decisions
Health Decisions (healthdec.com) is a global contract research organization (CRO) committed to helping drug and device companies achieve greater success. Our sponsors rely on us to help them prove the value of their pipelines both faster and with the smartest possible allocation of funds. Through Agile Clinical Development—a strategic combination of adaptive design and adaptive operations—Health Decisions optimizes every facet of clinical research from design protocol to the most detailed day-to-day management, so sponsors can make the most of competitive market opportunities.

Health Decisions is headquartered in Durham, NC, with over twenty years of experience helping sponsors achieve success in Phase I-IV trials across all major therapy areas. For more information, please visit the company's website at the URL accompanying this press release.

About MAGI’s Clinical Research Conference – 2010 West
MAGI’s Clinical Research Conference – 2010 West, is presented jointly by First Clinical Research and the International Institute for Business Information & Growth LLC (iiBIG). Held October 24 – 27 at The Fairmont San Francisco in San Francisco, CA, the conference features over 90 sessions and workshops in six tracks, for a comprehensive program that addresses operations, regulatory affairs, contracts and budgets.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Health Decisions

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Health Decisions CEO to Discuss at MAGI Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Katie Hendrick - HealthDec.com 
919-967-1111 x116 khendrick[.]healthdec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Health Decisions securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Health Decisions / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)